BLOOM Forward: Investigating Weight Loss Impact on TJAC Patients
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Oct 23, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The BLOOM Forward clinical trial is studying the effects of a weight loss program called BLOOM on patients who are living with obesity and are waiting for hip or knee surgery. The main goals of the trial are to see if participants can lose up to 10% of their body weight, if they can continue to lose weight for six months after the program ends, and if their overall quality of life improves as a result of the program. This program lasts for 24 weeks and is conducted online with the help of doctors and dietitians who provide support and guidance.
To be eligible for this study, participants must be at least 18 years old, have a body mass index (BMI) of 35 or higher, and have been identified as candidates for orthopedic surgery. They also need to have a referral from their primary care doctor and be willing to actively participate in the program. Throughout the trial, participants will complete questionnaires about their diet and quality of life, and they will have their height and weight measured at various points during the program. This trial is not yet recruiting participants, so those interested will need to wait for more information on how to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * To be eligible for the study, subjects must meet all the following criteria:
- • 1. Age ≥ 18 years old
- • 2. Body mass index (BMI) ≥ 35 kg/m2
- • 3. Have being identified as a potential orthopedic surgery candidate by the Total Joint Assessment Clinic (TJAC)
- • 4. Have a referral by their primary care practitioner
- • 5. Ready to participate actively in the program (i.e., readiness to change scale score ≥7)
- • 6. Acquisition of the required technology tools and skills to use the virtual platform (the BLOOM program will be conducted via virtual video conference)
- • 7. English comprehension at a level that allows for active participation in the program
- Exclusion Criteria:
- * Subjects who meet any of the following criteria are not eligible for the study:
- • 1. Active eating disorder
- • 2. Active substance use disorder
- • 3. Active smoking
- • 4. Currently or past enrollment in another weight loss program in the previous year prior to enrollment in the study
- • 5. Ongoing pregnancy or breastfeeding
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Judy Shiau, MD
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported